Glucose-Lowering Agents Developed in the Last Two Decades and Their Perioperative Implications.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Glucose-Lowering Agents Developed in the Last Two Decades and Their Perioperative Implications.
- Published In:
- Pharmaceuticals (Basel, Switzerland), 18(1) (2024)
- Authors:
- Goudra, Basavana, Merli, Geno J, Green, Michael
- Database ID:
- RPEP-08285
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-08285APA
Goudra, Basavana; Merli, Geno J; Green, Michael. (2024). Glucose-Lowering Agents Developed in the Last Two Decades and Their Perioperative Implications.. Pharmaceuticals (Basel, Switzerland), 18(1). https://doi.org/10.3390/ph18010004
MLA
Goudra, Basavana, et al. "Glucose-Lowering Agents Developed in the Last Two Decades and Their Perioperative Implications.." Pharmaceuticals (Basel, 2024. https://doi.org/10.3390/ph18010004
RethinkPeptides
RethinkPeptides Research Database. "Glucose-Lowering Agents Developed in the Last Two Decades an..." RPEP-08285. Retrieved from https://rethinkpeptides.com/research/goudra-2024-glucoselowering-agents-developed-in
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.